25-Hydroxycholesterol activates a cytochrome c release-mediated caspase cascade.

Area of Science:

• Cell Biology
• Biochemistry
• Molecular Biology

Background:

• 25-hydroxycholesterol (25-OHC) treated CHO-K1 cells serve as a model for studying oxidized low-density lipoprotein (LDL)-induced apoptosis in vascular cells.
• The current study focuses on the execution phase of apoptosis induced by 25-OHC in CHO-K1 cells.

Purpose of the Study:

• To investigate the execution phase of the apoptotic pathway in 25-hydroxycholesterol (25-OHC)-induced cell death.
• To elucidate the specific molecular events involved in oxysterol-induced apoptosis.

Main Methods:

• Utilized CHO-K1 cells treated with 25-hydroxycholesterol (25-OHC).
• Assessed caspase activation and mitochondrial cytochrome c release.
• Employed a competitive caspase-3 inhibitor (Ac-DEVD-CHO).
• Performed immunoblot analysis for poly(ADP-ribose) polymerase (PARP) degradation.

Main Results:

• Oxysterol-induced apoptosis in CHO-K1 cells was associated with caspase activation.
• Mitochondrial cytochrome c release preceded the observed apoptosis.
• Inhibition of caspase-3 prevented 25-OHC-induced apoptotic cell death.
• 25-OHC treatment led to the degradation of poly(ADP-ribose) polymerase (PARP), a caspase-3 substrate.

Conclusions:

• 25-hydroxycholesterol (25-OHC) activates the apoptotic machinery in CHO-K1 cells.
• Apoptosis induction involves the release of cytochrome c from mitochondria and subsequent activation of a caspase cascade.
• The findings confirm the role of caspases, specifically caspase-3, in mediating 25-OHC-induced cell death.